The relationship between the phageome and human health: are bacteriophages beneficial or harmful microbes?

Author:

Fernández L.12,Duarte A.C.12,Rodríguez A.12,García P.12

Affiliation:

1. Instituto de Productos Lácteos de Asturias (IPLA-CSIC), Paseo Río Linares s/n, 33300 Villaviciosa, Asturias, Spain.

2. DairySafe Group, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Av. del Hospital Universitario s/n, 33011 Oviedo, Spain.

Abstract

In the context of the global antibiotic resistance crisis, bacteriophages are increasingly becoming promising antimicrobial agents against multi-resistant bacteria. Indeed, a huge effort is being made to bring phage-derived products to the market, a process that will also require revising the current regulations in order to facilitate their approval. However, despite the evidence supporting the safety of phages for humans, the general public would still be reluctant to use ‘viruses’ for therapeutic purposes. In this scenario, we consider that it is important to discuss the role of these microorganisms in the equilibrium of the microbiota and how this relates to human health. To do that, this review starts by examining the role of phages as key players in bacterial communities (including those that naturally inhabit the human body), modulating the species composition and contributing to maintain a ‘healthy’ status quo. Additionally, in specific situations, e.g. an infectious disease, bacteriophages can be used as target-specific antimicrobials against pathogenic bacteria (phage therapy), while being harmless to the desirable microbiota. Apart from that, incipient research shows the potential application of these viruses to treat diseases caused by bacterial dysbiosis. This latter application would be comparable to the use of probiotics or prebiotics, since bacteriophages can indirectly improve the growth of beneficial bacteria in the gastrointestinal tract by removing undesirable competitors. On the other hand, possible adverse effects do not appear to be an impediment to promote phage therapy. Nonetheless, it is important to remember their potentially negative impact, mainly concerning their immunogenicity or their potential spread of virulence and antibiotic resistance genes, especially by temperate phages. Overall, we believe that phages should be largely considered beneficial microbes, although it is paramount not to overlook their potential risks.

Publisher

Wageningen Academic Publishers

Subject

Microbiology (medical),Microbiology

Reference102 articles.

1. Abeles, S.R., Ly, M., Santiago-Rodriguez, T.M. and Pride, D.T., 2015. Effects of long term antibiotic therapy on human oral and fecal viromes. PLoS ONE 10: e0134941. https://doi.org/10.1371/journal.pone.0134941.

2. Ackermann, H.W., 2007. 5500 Phages examined in the electron microscope. Archives of Virology 152: 227-243. https://doi.org/10.1007/s00705-006-0849-1.

3. Aleshkin, A.V., Rubalskii, E.O., Volozhantsev, N.V., Verevkin, V.V., Svetoch, E.A., Kiseleva, I.A., Bochkareva, S.S., Borisova, O.Y., Popova, A.V., Bogun, A.G. and Afanas’ev, S.S., 2015. A small-scale experiment of using phage-based probiotic dietary supplement for prevention of E. coli traveler’s diarrhea. Bacteriophage 5: e1074329. https://doi.org/10.1080/21597081.2015.1074329.

4. Anany, H., Chou, Y., Cucic, S., Derda, R., Evoy, S. and Griffiths, M.W., 2017. From bits and pieces to whole phage to nanomachines: pathogen detection using bacteriophages. Annual Review of Food Science and Technology 8: 305-329. https://doi.org/10.1146/annurev-food-041715-033235

5. Aslam, S., Courtwright, A.M., Koval, C., Lehman, S.M., Morales, S., Furr, C.L., Rosas, F., Brownstein, M.J., Fackler, J.R., Sisson, B.M., Biswas, B., Henry, M., Luu, T., Bivens, B.N., Hamilton, T., Duplessis, C., Logan, C., Law, N., Yung, G., Turowski, J., Anesi, J., Strathdee, S.A. and Schooley, R.T., 2019. Early clinical experience of bacteriophage therapy in 3 lung transplant recipients. American Journal of Transplantation 19: 2631-2639. https://doi.org/10.1111/ajt.15503

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3